Illkirch-Graffenstaden, France

Philippe Poindron

This inventor holds 1 USPTO granted patent. Top assignee: Synthelabo. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe Poindron. Retrieved from https://idiyas.com/inventor/philippe-poindron-w21bf54a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Philippe Poindron: Pioneering Nerve Regeneration

Introduction

Philippe Poindron is an innovative inventor based in Illkirch Cedex, France. With a remarkable focus on medical advancements, he has contributed significantly to the field of neuroregeneration. His work primarily revolves around creating effective treatments for peripheral neuropathies and chronic neurodegenerative diseases.

Latest Patents

Philippe holds a patent for a groundbreaking method for stimulating nerve regeneration. This patent details the use of eliprodil and its enantiomers in developing medicines aimed at treating various neurological disorders. This innovative approach highlights his commitment to improving patient outcomes and advancing medical science.

Career Highlights

Philippe Poindron works at Synthelabo, where he has been instrumental in pushing the boundaries of research in neurology. His dedication and expertise have made significant contributions to the pharmaceutical industry, showcasing his passion for innovation and invention.

Collaborations

Throughout his career, Philippe has collaborated with notable coworkers such as Serge Braun and Badia Ferzaz. These partnerships have played a crucial role in enhancing his research efforts and expanding the impact of his inventions in the field of medicine.

Conclusion

In summary, Philippe Poindron stands out as a pivotal figure in the realm of medical innovations. His patented method for nerve regeneration reflects his dedication to improving healthcare, making significant contributions through his work at Synthelabo. Through collaborations with esteemed colleagues, he continues to advocate for advancements in treatments for neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…